Breast Cancer. Breast, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: The patients with breast cancer; With written informed consent; 30-70 years old patients; The breast cancer patients in stages 2 and 3. Exclusion criteria: The patients with opioid addiction; The patients with the history of rheumatoid arthritis; The patients with the history of cancer.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The alteration of plasma expression level of the miRNAs. Timepoint: before and after treatment. Method of measurement: Real-Time PCR. | — |
Secondary
| Measure | Time frame |
|---|---|
| The expressions of metalloproteinases level. Timepoint: befor and after treatment. Method of measurement: Gelatin quantitative zymography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Cancer Research Center, Cancer Institute of Iran